Edition:
India

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

3.49USD
22 Jan 2018
Change (% chg)

-- (--)
Prev Close
$3.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
103,215
52-wk High
$22.16
52-wk Low
$3.21

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.009
Jun '17 0.00 -0.000
Mar '17 0.00 -0.011
FY 2016 Dec '16 0.00 -0.007
Sep '16 0.00 -0.000
Jun '16 0.00 -0.005
Mar '16 0.00 -0.003
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.72 -0.72 -0.72 --
Quarter Ending Jun-18 1 -0.72 -0.72 -0.72 --
Year Ending Dec-18 1 -2.79 -2.79 -2.79 -4.82
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 71.04 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akari Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 15.32%
# of Holders: 14
Total Shares Held: 2,337,806
3 Mo. Net Change: 10,000
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.